[Treatment of maxillary cancer].
In order to avoid post-operative cosmetic and functional disabilities, simultaneous combined surgery, radiotherapy and regional chemotherapy was introduced in treating carcinomas of the maxillary sinus. The combined therapy consists of a reduction operation succeeded by daily cleaning of the residual tumor, external irradiation and intra-arterial infusion of 5-fluorouracil and broxuridine. Thirty-six cases of squamous cell carcinoma of the maxillary sinus were treated between 1974 and 1981, and followed up for more than 2 years. Some modifications were made in order to decrease the incidences of local recurrences as well as distant metastasis. The result of these modifications in the combined treatment is too short of time and cases to estimate. However, 5 year survival rate of 10 cases analysed by life table method showed 88%.
D001973:Bromodeoxyuridine / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial; D008443:Maxillary Sinus; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D011879:Radiotherapy Dosage
D001973:Bromodeoxyuridine; D005472:Fluorouracil